SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-006263
Filing Date
2019-03-05
Accepted
2019-03-05 16:06:35
Documents
75
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kura-10k_20181231.htm 10-K 2498290
2 EX-10.24 kura-ex1024_86.htm EX-10.24 11910
3 EX-23.1 kura-ex231_11.htm EX-23.1 4860
4 EX-31.1 kura-ex311_8.htm EX-31.1 19614
5 EX-31.2 kura-ex312_10.htm EX-31.2 19623
6 EX-32.1 kura-ex321_6.htm EX-32.1 9439
  Complete submission text file 0001564590-19-006263.txt   8706616

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kura-20181231.xml EX-101.INS 1865369
8 XBRL TAXONOMY EXTENSION SCHEMA kura-20181231.xsd EX-101.SCH 66299
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20181231_cal.xml EX-101.CAL 55069
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20181231_def.xml EX-101.DEF 237080
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20181231_lab.xml EX-101.LAB 504282
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20181231_pre.xml EX-101.PRE 384809
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37620 | Film No.: 19658317
SIC: 2834 Pharmaceutical Preparations